North America Clinical Nutrition Market - Segmented by Route of Administration, Disease Type, End-user, and Geography - Growth, Trends, and Forecast (2018 - 2023)
The North America clinical nutrition market is expected to register a CAGR of 5.5%, during the forecast period, 2018 to 2023. Clinical nutrition is an area of medicine that offers treatment of medical disorders caused due to an improper diet or due to the body’s inability to absorb the nutrients available in a normal diet. Clinical nutrition products include clinical foods and dietary supplements that are categorized primarily as pharmaceuticals and are delivered through enteral and parenteral feeding. They are aimed at treating metabolic disorders, eating or nutritional disorders, and others.
Increasing Prevalence of Metabolic Disorders
The prevalence of metabolic disorders has increased over the past decade; however, this is only in terms of raw data. The actual number of patients going for the diagnosis of metabolic disorders has increased over the decade, hence, an increase in the number of patients diagnosed. Most of the metabolic syndromes result in situations where body lacks the capability to synthesize non-essential molecules, like vitamins, amino acids, and several molecules involved in metabolic pathways. Most of these conditions can be managed only with supplementation of one or two nutrients. For instance, vitamin D deficiency can be managed simply by using vitamin D tablets. But, the market is large, owing to metabolic disorders that last for a lifetime. Hence, once diagnosed, a patient becomes a lifelong customer, thus, compensating the low cost of single units. This, combined with increase in the number of patients being diagnosed with metabolic syndromes, is driving the growth of the clinical nutrition market. The other factor, such as High Spending on Healthcare is driving the North America clinical nutrition market.
Imprecise Perception about Clinical Nutrition
In most parts of the North America (other than cases where malnutrition arises due to lack of proper food or affordability of proper food), people believe that any malnutrition can be simply treated by making required dietary changes. They fail to realize that malnutrition is not always due to improper diet and can be due to many other conditions, such as nutrient absorption disorders or metabolic syndromes. This misconception about clinical nutrition prevents many people (particularly from emerging and third-world countries) from even visiting healthcare professionals or even following their instructions and using clinical nutrition (as most people in these countries consider clinical nutrition used only by severely ill people). These false perceptions about malnutrition in general and clinical nutrition in particular are restraining the growth of the North America clinical nutrition market. The other factor, such as unwillingness of hospitals and in-house pharmacies/dispensaries to maintain the required stock of clinical nutrition products is also hindering the growth of the market.
US Lead the Market in North America Region
The US clinical nutrition market holds the largest market share in 2017 in North America region and the clinical nutrition market was estimated at USD 5898.3 million in 2017 and is expected to reach USD 8204.31 million by 2023 registering a CAGR of 6%.
Key Developments in the Market: